Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Thyroid Gland

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Synthesis and Functions of Calcitonin

Synthesis and Functions of Calcitonin

Calcitonin, a vital polypeptide hormone, regulates calcium levels within body fluids. It is released by the parafollicular cells, also known as C cells, situated in the follicular epithelium of the thyroid gland. Calcitonin responds to fluctuations in blood calcium levels and the influence of gastrointestinal hormones like gastrin and cholecystokinin.
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A differentiated thyroid carcinoma-specific graded prognostic assessment for brain metastases: derivation in a 10,306-patient cohort and external validation.

Journal of neuro-oncology·2026

Same author

Real-World Experience with Lenvatinib plus Pembrolizumab in Metastatic <i>BRAF</i> Wild-Type Anaplastic Thyroid Carcinoma.

Thyroid : official journal of the American Thyroid Association·2026

Same author

Acquired Driver Fusions as a Mechanism of Resistance to Selective RET Inhibitors in Advanced Medullary Thyroid Carcinoma.

JCO precision oncology·2026

Same author

Role of the ETV5/p38 Signaling Axis in Aggressive Thyroid Cancer Cells.

Molecular cancer therapeutics·2026

Same author

Increasing Access and Quality Care for Immune Checkpoint Inhibitor-Related Thyroid Dysfunction.

JCO oncology practice·2025

Same author

The shifting landscape of germline RET pathogenic variants with the introduction of panel testing.

Surgery·2025

Same journal

EDITORIAL INTRODUCTION.

Current opinion in endocrinology, diabetes, and obesity·2026

Same journal

Exploring the role of parathyroid hormone in sarcopenia: A review.

Current opinion in endocrinology, diabetes, and obesity·2026

Same journal

Normocalcemic primary hyperparathyroidism: an update on diagnostic and management challenges.

Current opinion in endocrinology, diabetes, and obesity·2026

Same journal

Prediabetes before pregnancy: implications for risk stratification and research.

Current opinion in endocrinology, diabetes, and obesity·2026

Same journal

Secondary hyperparathyroidism in chronic kidney disease: update on pathophysiology and new treatment targets.

Current opinion in endocrinology, diabetes, and obesity·2026

Same journal

Revisiting the relationship between weight loss and bone health in people living with obesity: insights from the latest evidence.

Current opinion in endocrinology, diabetes, and obesity·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Oct 27, 2025

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Medullary thyroid carcinoma.

Tania Jaber¹, Ramona Dadu², Mimi I Hu²

¹Division of Endocrinology, Hamad Medical Corporation, Doha, Qatar.

Current Opinion in Endocrinology, Diabetes, and Obesity

|July 22, 2021

Summary

This summary is machine-generated.

Recent advancements in medullary thyroid cancer (MTC) include improved diagnosis and targeted therapies like RET inhibitors. Further research is needed for patients with resistance or non-actionable mutations.

More Related Videos

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

Related Experiment Videos

Last Updated: Oct 27, 2025

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

Area of Science:

Oncology
Genetics
Endocrinology

Background:

Medullary thyroid cancer (MTC) diagnosis and management have seen significant progress.
Understanding MTC pathogenesis, including driver mutations and tumor microenvironment, is crucial.

Purpose of the Study:

To review recent developments in medullary thyroid cancer (MTC) diagnosis and management.
Focus on pathogenesis, systemic therapy, and future therapeutic directions.

Main Methods:

Review of recent literature on MTC diagnosis and treatment.
Analysis of mutational analysis, genomic alterations, and therapeutic agents.

Main Results:

Mutational analysis enhances MTC diagnostic accuracy.
New genomic alterations and overexpression factors improve prognostication and identify therapeutic targets.
Selective rearranged during transfection (RET) inhibitors show promise for RET-mutated MTC, but resistance is a concern.
Emerging evidence suggests MTC may be immunogenic, reviving interest in immune-based therapies.

Conclusions:

Advances in understanding MTC driver mutations enable more tolerable therapeutics.
Effective strategies are still needed for patients with non-actionable mutations or treatment resistance.